BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 35796726)

  • 1. Impairment of perioperative activities of daily living is associated with poor prognosis following hepatectomy for hepatocellular carcinoma.
    Mima K; Imai K; Kaida T; Matsumoto T; Nakagawa S; Sawayama H; Hayashi H; Yamashita YI; Baba H
    J Surg Oncol; 2022 Nov; 126(6):995-1002. PubMed ID: 35796726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impairment of Activities of Daily Living is an Independent Risk Factor for Recurrence and Mortality Following Curative Resection of Stage I-III Colorectal Cancer.
    Mima K; Kosumi K; Miyanari N; Tajiri T; Kanemitsu K; Takematsu T; Inoue M; Mizumoto T; Kubota T; Baba H
    J Gastrointest Surg; 2021 Oct; 25(10):2628-2636. PubMed ID: 33825120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perioperative disabilities in activities of daily living are associated with worse prognosis after hepatectomy for colorectal liver metastasis.
    Mima K; Hayashi H; Maruno M; Yumoto S; Matsumoto T; Tsukamoto M; Miyata T; Nakagawa S; Nitta H; Imai K; Baba H
    HPB (Oxford); 2024 Feb; 26(2):203-211. PubMed ID: 37770363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disability in perioperative activities of daily living is associated with worse survival outcomes following hepatic resection in patients with intrahepatic cholangiocarcinoma.
    Mima K; Hayashi H; Yumoto S; Matsumoto T; Tsukamoto M; Miyata T; Nakagawa S; Nitta H; Baba H
    Hepatol Res; 2023 Feb; 53(2):135-144. PubMed ID: 36305859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A new prognostic score system of hepatocellular carcinoma following hepatectomy].
    Wang YK; Bi XY; Li ZY; Zhao H; Zhao JJ; Zhou JG; Huang Z; Zhang YF; Li MX; Chen X; Wu XL; Mao R; Hu XH; Hu HJ; Liu JM; Cai JQ
    Zhonghua Zhong Liu Za Zhi; 2017 Dec; 39(12):903-909. PubMed ID: 29262506
    [No Abstract]   [Full Text] [Related]  

  • 6. Association Between Noninvasive Fibrosis Markers and Postoperative Mortality After Hepatectomy for Hepatocellular Carcinoma.
    Maegawa FB; Shehorn L; Aziz H; Kettelle J; Jie T; Riall TS
    JAMA Netw Open; 2019 Jan; 2(1):e187142. PubMed ID: 30657533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Surgical treatment of primary liver cancer:a report of 10 966 cases].
    Xia YX; Zhang F; Li XC; Kong LB; Zhang H; Li DH; Cheng F; Pu LY; Zhang CY; Qian XF; Wang P; Wang K; Wu ZS; Lyu L; Rao JH; Wu XF; Yao AH; Shao WY; Fan Y; You W; Dai XZ; Qin JJ; Li MY; Zhu Q; Wang XH
    Zhonghua Wai Ke Za Zhi; 2021 Jan; 59(1):6-17. PubMed ID: 33412628
    [No Abstract]   [Full Text] [Related]  

  • 8. The 10-year Survival Analysis of Radiofrequency Ablation for Solitary Hepatocellular Carcinoma 5 cm or Smaller: Primary versus Recurrent HCC.
    Bai XM; Cui M; Yang W; Wang H; Wang S; Zhang ZY; Wu W; Chen MH; Yan K; Goldberg SN
    Radiology; 2021 Aug; 300(2):458-469. PubMed ID: 34003058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical efficacy of postoperative adjuvant transcatheter arterial chemoembolization on hepatocellular carcinoma.
    Liu C; Sun L; Xu J; Zhao Y
    World J Surg Oncol; 2016 Apr; 14():100. PubMed ID: 27038790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longterm prognosis after hepatic resection for small hepatocellular carcinoma.
    Shimozawa N; Hanazaki K
    J Am Coll Surg; 2004 Mar; 198(3):356-65. PubMed ID: 14992736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical efficacy and prognostic factors analysis following curative hepatectomy for hepatocellular carcinoma patients with different China Liver Cancer Staging].
    Li CX; Zhang H; Wu XF; Han S; Jiao CY; Wang D; Wang K; Li XC
    Zhonghua Wai Ke Za Zhi; 2021 Feb; 59(2):134-143. PubMed ID: 33378806
    [No Abstract]   [Full Text] [Related]  

  • 12. No impact of perioperative blood transfusion on recurrence of hepatocellular carcinoma after hepatectomy.
    Kuroda S; Tashiro H; Kobayashi T; Oshita A; Amano H; Ohdan H
    World J Surg; 2012 Mar; 36(3):651-8. PubMed ID: 22270991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors of disease-free and overall survival in patients with hepatocellular carcinoma undergoing partial hepatectomy in curative intent.
    Lurje G; Bednarsch J; Czigany Z; Amygdalos I; Meister F; Schöning W; Ulmer TF; Foerster M; Dejong C; Neumann UP
    Langenbecks Arch Surg; 2018 Nov; 403(7):851-861. PubMed ID: 30267147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of hepatectomy for elderly patients with hepatocellular carcinoma.
    Kishida N; Hibi T; Itano O; Okabayashi K; Shinoda M; Kitago M; Abe Y; Yagi H; Kitagawa Y
    Ann Surg Oncol; 2015 Sep; 22(9):3094-101. PubMed ID: 25582743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RAM score is an effective predictor for early mortality and recurrence after hepatectomy for hepatocellular carcinoma.
    Hsu HY; Yu MC; Lee CW; Tsai HI; Sung CM; Chen CW; Huang SW; Lin CY; Jeng WJ; Lee WC; Chen MF
    BMC Cancer; 2017 Nov; 17(1):742. PubMed ID: 29121890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of preoperative aspartate aminotransferase to neutrophil ratio index in patients with hepatocellular carcinoma after hepatic resection.
    Ji F; Fu S; Guo Z; Pang H; Chen D; Wang X; Ju W; Wang D; He X; Hua Y; Peng B
    Oncotarget; 2016 Nov; 7(44):72276-72289. PubMed ID: 27472390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postoperative morbidity adversely impacts long-term oncologic prognosis following hepatectomy for hepatocellular carcinoma: A multicenter observational study.
    Li LQ; Liang L; Sun LY; Li C; Wu H; Zhang YM; Zhang WG; Wang H; Zhou YH; Gu WM; Chen TH; Li J; Liang YJ; Xu QR; Diao YK; Jia HD; Wang MD; Zhang CW; Shen F; Huang DS; Yang T
    Eur J Surg Oncol; 2021 Oct; 47(10):2551-2560. PubMed ID: 33934940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repeat hepatectomy for patients with early and late recurrence of hepatocellular carcinoma: A multicenter propensity score matching analysis.
    Xing H; Sun LY; Yan WT; Quan B; Liang L; Li C; Zhou YH; Wang H; Zhong JH; Gu WM; Chen TH; Wang MD; Wu H; Pawlik TM; Lau WY; Wu MC; Shen F; Yang T
    Surgery; 2021 Apr; 169(4):911-920. PubMed ID: 31879090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrence after liver resection for hepatocellular carcinoma: risk factors, treatment, and outcomes.
    Shah SA; Cleary SP; Wei AC; Yang I; Taylor BR; Hemming AW; Langer B; Grant DR; Greig PD; Gallinger S
    Surgery; 2007 Mar; 141(3):330-9. PubMed ID: 17349844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perioperative exercise capacity in chronic liver injury patients with hepatocellular carcinoma undergoing hepatectomy.
    Kaibori M; Matsui K; Yoshii K; Ishizaki M; Iwasaka J; Miyauchi T; Kimura Y
    PLoS One; 2019; 14(8):e0221079. PubMed ID: 31412075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.